Citation Impact
Citing Papers
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America
2010 Standout
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)
2017 Standout
Chagas disease
2010 Standout
Oncological applications of FDG PET imaging: brain tumors, colorectal cancer, lymphoma and melanoma.
1999
Chagas' heart disease.
1995
Early Versus Delayed Antiretroviral Therapy and Cerebrospinal Fluid Fungal Clearance in Adults With HIV and Cryptococcal Meningitis
2013 StandoutNobel
Correcting for Noncompliance and Dependent Censoring in an AIDS Clinical Trial with Inverse Probability of Censoring Weighted (IPCW) Log‐Rank Tests
2000
Diagnosis of AIDS-related focal brain lesions
1997
Evolution of Vaginal Candida Species Recovered from Human Immunodeficiency Virus‐Infected Women Receiving Fluconazole Prophylaxis: The Emergence of Candida glabrata?
1999
Vulvovaginal candidosis
2007 Standout
Randomized trial of dapsone and aerosolized pentamidine for the prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis
1993
Prophylaxis with Weekly Versus Daily Fluconazole for Fungal Infections in Patients with AIDS
1998
A randomized trial of continuous or intermittent therapy with fluconazole for oropharyngeal candidiasis in HIV-infected patients: clinical outcomes and development of fluconazole resistance
1998
The role of porphyrin chemistry in tumor imaging and photodynamic therapy
2010 Standout
A randomized, double‐blind, placebo‐controlled study of itraconazole capsules for the prevention of deep fungal infections in immunodeficient patients with HIV infection
2001
Itraconazole oral solution versus clotrimazole troches for the treatment of oropharyngeal candidiasis in immunocompromised patients
1997
A Randomized, Double‐Blind Comparison of Itraconazole Oral Solution and Fluconazole Tablets in the Treatment of Esophageal Candidiasis
1997
Treatment of Fluconazole-Refractory Oropharyngeal Candidiasis with Itraconazole Oral Solution in HIV-Positive Patients
1999
Acute Respiratory Failure Associated with Cryptococcosis in Patients with AIDS: Analysis of Predictive Factors
1998
PET and [18F]-FDG in oncology: A clinical update
1996
Recent Advances in the Management of Cryptococcal Meningitis in Patients with AIDS
1996
Randomized Trial of Itraconazole Oral Solution for Oropharyngeal Candidiasis in HIV/AIDS Patients
1998
Congenital Chagas' Disease: Diagnostic and Clinical Aspects
1995
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
2013 Standout
Treatment of sporotrichosis with itraconazole
1993
A Randomized Study of the Use of Fluconazole in Continuous versus Episodic Therapy in Patients with Advanced HIV Infection and a History of Oropharyngeal Candidiasis: AIDS Clinical Trials Group Study 323/Mycoses Study Group Study 40
2005
Successful Medical Management of Isolated Renal Zygomycosis: Case Report and Review
1998
<![CDATA[<B>Evaluation of efficacy and safety of itraconazole oral solution for the treatment of oropharyngeal candidiasis in AIDS patients</B>]]>
2001
Anti–β1-adrenergic receptor antibodies and heart failure: causation, not just correlation
2004 StandoutNobel
A Randomized Trial of Three Antipneumocystis Agents in Patients with Advanced Human Immunodeficiency Virus Infection
1995
Risks and benefits of aerosolized pentamidine and cotrimoxazole in primary prophylaxis of Pneumocystis carinii pneumonia in HIV-1-infected patients: a two-year Italian multicentric randomized controlled trial
1996
The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance
1996
PI3K signaling of autophagy is required for starvation tolerance and virulenceof Cryptococcus neoformans
2008 StandoutNobel
Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases
2005 Standout
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Evolution of Antifungal Susceptibility amongCandidaSpecies Isolates Recovered from Human Immunodeficiency Virus–Infected Women Receiving Fluconazole Prophylaxis
2001
Cryptococcosis
2006
Graphical Tools for Network Meta-Analysis in STATA
2013 Standout
The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials
1997 Standout
Changing AIDS-risk behavior.
1992 Standout
Cryptococcosis: Population‐Based Multistate Active Surveillance and Risk Factors in Human Immunodeficiency Virus–Infected Persons
1999
Morbidity and Mortality in South African Gold Miners: Impact of Untreated Disease Due to Human Immunodeficiency Virus
2002
Severe Hypomagnesemia Induced by Pentamidine
1990
Fluconazole vs Itraconazole-Flucytosine Association in the Treatment of Esophageal Candidiasis in AIDS Patients
1996
Prophylaxis against Opportunistic Infections in Patients with Human Immunodeficiency Virus Infection
2000
The Changing Epidemiology of Cryptococcosis: An Update from Population‐Based Active Surveillance in 2 Large Metropolitan Areas, 1992–2000
2003
Refractory Mucosal Candidiasis in Patients with Human Immunodeficiency Virus Infection
1998
Deep sinus aspergillosis in a liver transplant recipient successfully treated with a combination of caspofungin and voriconazole
2004
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes
2015 Standout
Clinical Pharmacology of Systemic Antifungal Agents: A Comprehensive Review of Agents in Clinical Use, Current Investigational Compounds, and Putative Targets for Antifungal Drug Development
1998
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale
2001 Standout
Systemic Sporotrichosis Treated with Itraconazole
1993
Meta-Analysis of Prophylactic Treatments Against Pneumocystis carinii Pneumonia and Toxoplasma Encephalitis in HIV-Infected Patients
1997
Isolation of Fluconazole-Resistant Candida albicans from Human Immunodeficiency Virus-Negative Patients Never Treated with Azoles
1995
Diagnosis and Management of Increased Intracranial Pressure in Patients with AIDS and Cryptococcal Meningitis
2000
The Future of Antifungal Therapy
1996
Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS
2009 Standout
Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production
1999 Standout
Sex and inflammation in respiratory diseases: a clinical viewpoint
2013
Oral Azole Drugs as Systemic Antifungal Therapy
1994
Once-Weekly Administration of Dapsone/Pyrimethamine vs. Aerosolized Pentamidine as Combined Prophylaxis for Pneumocystis carinii Pneumonia and Toxoplasmic Encephalitis in Human Immunodeficiency Virus-Infected Patients
1995
Hemophilia-associated AIDS in the United States, 1981 to September 1987.
1988
Dapsone-Pyrimethamine Compared with Aerosolized Pentamidine as Primary Prophylaxis against Pneumocystis carinii Pneumonia and Toxoplasmosis in HIV Infection
1993
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
2005 Standout
Problems and Controversies in the Management of Hematogenous Candidiasis
1996
Resistant Candidiasis
1994
Fluconazole Prophylaxis against Fungal Colonization and Infection in Preterm Infants
2001
Theories of reasoned action and planned behavior as models of condom use: A meta-analysis.
2001 Standout
Antifungal activity of a new triazole, D0870, compared with four other antifungal agents tested against clinical isolates of Candida and Torulopsis glabrata
1994
Role of Azoles in Antifungal Therapy
1996
Treatment with intravenously administered gamma globulin of chronic relapsing colitis induced by Clostridium difficile toxin
1991
Efficacy and safety of Amphotericin B Lipid Complex Injection (ABLC) in solid‐organ transplant recipients with invasive fungal infections
2000
Pulmonary Cryptococcosis: Localized and Disseminated Infections in 27 Patients with AIDS
1995
Reporting the study populations of clinical trials
2000
Recent Advances in Pulmonary Medicine
1993
Infection in Solid-Organ Transplant Recipients
2007 Standout
18-F-fluorodeoxyglucose-positron emission tomography as a new approach to detect lymphomatous bone marrow.
1998
Itraconazole Prophylaxis for Fungal Infections in Patients with Advanced Human Immunodeficiency Virus Infection: Randomized, Placebo‐Controlled, Double‐Blind Study
1999
Guidelines for the Prevention of Intravascular Catheter-related Infections
2011 Standout
Comparison of 8 vs 15 Days of Antibiotic Therapy for Ventilator-Associated Pneumonia in Adults
2003 Standout
Zygomycosis
2002
FUNGAL INFECTIONS IN PATIENTS WITH ACQUIRED IMMUNODEFICIENCY SYNDROME
1997
External validity of randomised controlled trials: “To whom do the results of this trial apply?”
2005 Standout
Coccidioidomycosis in Human Immunodeficiency Virus–Infected Persons in Arizona, 1994–1997: Incidence, Risk Factors, and Prevention
2000
Randomized Study of Sulfamethoxazole-trimethoprim versus Aerosolized Pentamidine for Secondary Prophylaxis of Pneumocystis carinii Pneumonia in Patients with AIDS
1995
Antibiotic-Associated Diarrhea
2002 Standout
Comparison of Caspofungin and Amphotericin B for Invasive Candidiasis
2002 Standout
Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients
1999
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
2007 Standout
A Controlled Trial of Itraconazole as Primary Prophylaxis for Systemic Fungal Infections in Patients with Advanced Human Immunodeficiency Virus Infection in Thailand
2002
Epstein–Barr Virus Infection
2000 Standout
Fluconazole
1995
Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults
2002
Ventilator-associated Pneumonia
2002 Standout
An Official American Thoracic Society Statement: Treatment of Fungal Infections in Adult Pulmonary and Critical Care Patients
2010
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Candida Infections: Outcome and Attributable ICU Costs in Critically Ill Patients
2000
AIDS risk behavior patterns among gay men in small southern cities.
1990
Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.
2009
Magnesium in Man: Implications for Health and Disease
2014 Standout
2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis
2016 Standout
Adolescent Sexual Behavior, Drug Use, and Violence: Increased Reporting with Computer Survey Technology
1998 StandoutScience
Prevention of Infection Due toPneumocystisspp. in Human Immunodeficiency Virus-Negative Immunocompromised Patients
2004
Antifungal susceptibility testing
1993
Acute right-sided hemorrhagic colitis associated with oral administration of ampicillin
1979
Chemical Routes for the Transformation of Biomass into Chemicals
2007 Standout
Conazoles
2010
Fungal Infections of the Genitourinary System
1993
Current and Emerging Azole Antifungal Agents
1999 Standout
Antifungal prophylaxis during neutropenia and immunodeficiency
1997
Infection Due to Fluconazole-Resistant Candida in Patients with AIDS: Prevalence and Microbiology
1997
Bronchoscopic diagnosis of pneumonia
1994
Candida Infections: Outcome and Attributable ICU Costs in Critically Ill Patients
2000
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
2015 Standout
In vitro activities of voriconazole (UK-109,496) against fluconazole-susceptible and -resistant Candida albicans isolates from oral cavities of patients with human immunodeficiency virus infection
1997
Fluconazole for the management of invasive candidiasis: where do we stand after 15 years?
2006
Invasive Candidiasis
2015 Standout
Interpretive Breakpoints for Fluconazole and Candida Revisited: a Blueprint for the Future of Antifungal Susceptibility Testing
2006
Clinical, Cellular, and Molecular Factors That Contribute to Antifungal Drug Resistance
1998
Clostridium difficile--Associated diarrhea: A review.
2001
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
In vitro and in vivo efficacies of the azole SCH56592 against Cryptococcus neoformans
1996
Prior Antimicrobial Therapy and Risk for Hospital-Acquired Candida glabrata and Candida krusei Fungemia: a Case-Case-Control Study
2005
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Male‐male sexual contact in the U.S.A.: Findings from five sample surveys, 1970–1990
1991
Patterns of in vitro activity of itraconazole and imidazole antifungal agents against Candida albicans with decreased susceptibility to fluconazole from Spain
1995
Structure-In Vitro Activity Relationships of Pentamidine Analogues and Dication-Substituted Bis-Benzimidazoles as New Antifungal Agents
1998
Clinical Correlates of Antifungal Macrodilution Susceptibility Test Results for Non-AIDS Patients with Severe Candida Infections Treated with Fluconazole
2000
Epidemiology of Chagas disease in non endemic countries: the role of international migration
2007
Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia. NIAID Mycoses Study Group and the Candidemia Study Group
1995
Sexual behaviour in aids‐related research: Reliability and validity of recall and diary measures
1990
Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification
2014 Standout
Prevention of Infection Due toPneumocystis carinii
1998
Selection of candidate quality control isolates and tentative quality control ranges for in vitro susceptibility testing of yeast isolates by National Committee for Clinical Laboratory Standards proposed standard methods
1994
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
2008 Standout
Use of amphotericin B with azole antifungal drugs: what are we doing?
1995
The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration
2001 Standout
Resistance of Candida species to fluconazole
1995
Serum posaconazole levels among haematological cancer patients taking extended release tablets is affected by body weight and diarrhoea: single centre retrospective analysis
2015
Hemorrhagic Colitis Associated with a RareEscherichia coliSerotype
1983 Standout
Guidelines for Treatment of Candidiasis
2004 Standout
Behavioral risk reduction for HIV infection among gay and bisexual men: A review of results from the United States.
1988
Comparative study of broth macrodilution and microdilution techniques for in vitro antifungal susceptibility testing of yeasts by using the National Committee for Clinical Laboratory Standards' proposed standard
1994
Susceptibility testing of fungi: current status of correlation of in vitro data with clinical outcome
1996
Superior Serum Concentrations with Posaconazole Delayed-Release Tablets Compared to Suspension Formulation in Hematological Malignancies
2015
Azole resistance in oropharyngeal Candida albicans strains isolated from patients infected with human immunodeficiency virus
1994
Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans
1995 Standout
Palatal necrosis in an AIDS patient: a case of mucormycosis.
2000
Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's Lymphomas
1999 Standout
Switching from Posaconazole Suspension to Tablets Increases Serum Drug Levels in Leukemia Patients without Clinically Relevant Hepatotoxicity
2014
Works of Hetty Waskin being referenced
Phase 1b Study of New Posaconazole Tablet for Prevention of Invasive Fungal Infections in High-Risk Patients with Neutropenia
2014
Differences between men and women with HIV-related Pneumocystis carinii pneumonia: experience from 3,070 cases in New York City in 1987.
1993
A Randomized Trial Comparing Fluconazole with Clotrimazole Troches for the Prevention of Fungal Infections in Patients with Advanced Human Immunodeficiency Virus Infection
1995
Manifestations of Pulmonary Cryptococcusis in Patients with Acquired Immunodeficiency Syndrome
1990
Zygomycosis (Mucormycosis) and HIV Infection: Report of Three Cases and Review
1995
treatment of Systematic Sporotrichosis with Ketoconazole
1990
Prevalence of antibody to Trypanosoma cruzi among blood donors in Los Angeles, California
1991
Persistence of High-Risk Sexual Activity among Homosexual Men in an Area of Low Incidence of the Acquired lmmunodeficiency Syndrome
1987
Prevention of clindamycin-induced colitis in hamsters by Clostridium sordellii antitoxin.
1979
A Controlled Trial of Trimethoprim–Sulfamethoxazole or Aerosolized Pentamidine for Secondary Prophylaxis ofPneumocystis cariniiPneumonia in Patients with the Acquired Immunodeficiency Syndrome
1992
Prevention of clindamycin-induced colitis in hamsters by Clostridium sordellii antitoxin
1979
Aerosol pentamidine prophylaxis following Pneumocystis carinii pneumonia in AIDS patients: Results of a blinded dose-comparison study using an ultrasonic nebulizer
1991
Risk Factors for Hypoglycemia Associated With Pentamidine Therapy for Pneumocystis Pneumonia
1988
AMPHOTERICIN B CONCENTRATIONS IN AUTOPSY TISSUES OF ORGAN TRANSPLANT PATIENTS ADMINISTERED AMPHOTERICIN B LIPID COMPLEX INJECTION
1999
FDG-PET in differentiating lymphoma from nonmalignant central nervous system lesions in patients with AIDS.
1993
Posaconazole Tablet Pharmacokinetics: Lack of Effect of Concomitant Medications Altering Gastric pH and Gastric Motility in Healthy Subjects
2014
Correlation of in vitro fluconazole resistance of Candida isolates in relation to therapy and symptoms of individuals seropositive for human immunodeficiency virus type 1
1993
Aerosol pentamidine prophylaxis following pneumocystis carinii pneumonia in AIDS patients: Results of a blinded dose-comparison study using an ultrasonic nebulizer
1991
Prevalence of HTLV-III antibody among New Mexico residents with hemophilia.
1986